---
title: Newsroom | Drug Discovery & Development (6)
description: Drug Discovery & Development |  (6)
---

[![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/)

- [Newsroom](https://news.lifesciencenewswire.com/newsroom)
- [Back to the main site](https://lifesciencenewswire.com/)

![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1")

# Newsroom

#### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow")

#### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg)

![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg)

### Choose a Category

- [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture)
- [AI (3)](https://news.lifesciencenewswire.com/newsroom/tag/ai)
- [Analytical Chemistry (43)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry)
- [Biomanufacturing (37)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing)
- [biopharma (24)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)
- [Bioprocessing (17)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing)
- [Biotechnology (256)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology)
- [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture)
- [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)
- [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)
- [Clinical Research & Trials (118)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)
- [Computing & Technology (63)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it)
- [Conferences & Events (1)](https://news.lifesciencenewswire.com/newsroom/tag/conferences-events)
- [Corporate, Finance & Investor (290)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)
- [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)
- [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory)
- [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology)
- [Drug Discovery & Development (156)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)
- [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment)
- [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients)
- [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage)
- [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry)
- [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory)
- [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science)
- [Healthcare (138)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare)
- [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)
- [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science)
- [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing)
- [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science)
- [Medical Devices & Technology (28)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)
- [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)
- [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging)
- [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech)
- [Omics & Genetics (90)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics)
- [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology)
- [Pharma (119)](https://news.lifesciencenewswire.com/newsroom/tag/pharma)
- [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy)
- [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research)
- [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary)
- [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water)

See all

### Subscribe to Email Updates

<https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Tillotts Pharma and TVM Capital Life Science announce formation of Mage Biologics to develop innovative oral antibody therapy for ulcerative colitis](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis)

 July 20, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 20, 2023, 1:18:59 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/promocell-launches-promoexq-msc-growth-medium-xf-for-gmp-compliant-long-term-expansion-of-mesenchymal-stem-cells>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)

#### [PromoCell Launches PromoExQ MSC Growth Medium XF for GMP Compliant Long-term Expansion of Mesenchymal Stem Cells](https://news.lifesciencenewswire.com/newsroom/promocell-launches-promoexq-msc-growth-medium-xf-for-gmp-compliant-long-term-expansion-of-mesenchymal-stem-cells)

 July 19, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/promocell-launches-promoexq-msc-growth-medium-xf-for-gmp-compliant-long-term-expansion-of-mesenchymal-stem-cells)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/promocell-launches-promoexq-msc-growth-medium-xf-for-gmp-compliant-long-term-expansion-of-mesenchymal-stem-cells#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 19, 2023, 5:51:57 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)

#### [PrecisionLife identifies first detailed genetic risk factors for long COVID and common mechanisms with ME/CFS and other complex diseases](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases)

 July 18, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 18, 2023, 12:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/vitadao-launches-vita-fast-tokens-revolutionizing-governance-in-longevity-research>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [clinical research](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)

#### [VitaDAO launches VITA-FAST tokens, revolutionizing governance in longevity research](https://news.lifesciencenewswire.com/newsroom/vitadao-launches-vita-fast-tokens-revolutionizing-governance-in-longevity-research)

 June 30, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/vitadao-launches-vita-fast-tokens-revolutionizing-governance-in-longevity-research)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/vitadao-launches-vita-fast-tokens-revolutionizing-governance-in-longevity-research#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 30, 2023, 1:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/precisionlife-licenses-university-of-oxford-data-to-discover-personalised-treatments-for-endometriosis-patients>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [PrecisionLife licenses University of Oxford data to discover personalised treatments for endometriosis patients](https://news.lifesciencenewswire.com/newsroom/precisionlife-licenses-university-of-oxford-data-to-discover-personalised-treatments-for-endometriosis-patients)

 June 29, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-licenses-university-of-oxford-data-to-discover-personalised-treatments-for-endometriosis-patients)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-licenses-university-of-oxford-data-to-discover-personalised-treatments-for-endometriosis-patients#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 29, 2023, 9:00:00 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/oncodesign-services-announce-access-to-imaginabs-cd8-immunopet-technology>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology](https://news.lifesciencenewswire.com/newsroom/oncodesign-services-announce-access-to-imaginabs-cd8-immunopet-technology)

 June 27, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/oncodesign-services-announce-access-to-imaginabs-cd8-immunopet-technology)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/oncodesign-services-announce-access-to-imaginabs-cd8-immunopet-technology#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 27, 2023, 3:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/precisionlife-announces-strategic-cns-drug-development-collaboration-with-nanopharmaceutics>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [PrecisionLife announces strategic CNS drug development collaboration with Nanopharmaceutics](https://news.lifesciencenewswire.com/newsroom/precisionlife-announces-strategic-cns-drug-development-collaboration-with-nanopharmaceutics)

 June 15, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-announces-strategic-cns-drug-development-collaboration-with-nanopharmaceutics)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-announces-strategic-cns-drug-development-collaboration-with-nanopharmaceutics#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 15, 2023, 1:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-joins-cepi-in-advancing-global-epidemic-preparedness-and-response>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Synexa Life Sciences joins CEPI in advancing global epidemic preparedness and response](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-joins-cepi-in-advancing-global-epidemic-preparedness-and-response)

 May 30, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-joins-cepi-in-advancing-global-epidemic-preparedness-and-response)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-joins-cepi-in-advancing-global-epidemic-preparedness-and-response#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 30, 2023, 11:00:00 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/oncodesign-services-and-veritas-in-silico-enter-into-business-cooperation-on-developing-mrna-targeted-small-molecule-drugs>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Oncodesign Services and Veritas In Silico enter into business cooperation on developing mRNA-targeted small molecule drugs](https://news.lifesciencenewswire.com/newsroom/oncodesign-services-and-veritas-in-silico-enter-into-business-cooperation-on-developing-mrna-targeted-small-molecule-drugs)

 May 24, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/oncodesign-services-and-veritas-in-silico-enter-into-business-cooperation-on-developing-mrna-targeted-small-molecule-drugs)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/oncodesign-services-and-veritas-in-silico-enter-into-business-cooperation-on-developing-mrna-targeted-small-molecule-drugs#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 24, 2023, 11:00:00 AM

- [Tweet](https://twitter.com/share)

[Previous](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/5) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/7)

##### Browse more news

## Recent releases

<https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr>

#### [Alyssum Therapeutics Presents Phase 1 Results for First-in-Class CMTR2 Inhibitor AT-1965 at EORTC-NC...](https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr)

 November 19, 2026

Alyssum Therapeutics Inc., a clinical stage biopharmaceutical company developing a pipeline of first in class therapeutics through a patented technolo...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr)

<https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026>

#### [Sciensus Nurses to Present Data on Scalp Cooling Access, Virtual Peer Support and Post-Incident Clin...](https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026)

 November 11, 2026

Sciensus, a leading European life sciences organisation focused on accelerating patients' access to life-saving medicines, will present three posters ...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026)

<https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency>

#### [Biognosys Launches Industrialized Discovery to Deliver Scalable, AI-ready Proteomics with Exceptiona...](https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency)

 November 10, 2026

AI-ready data by design: Standardized, quality-controlled and reproducible quantitative proteomics data, built for integration into large-scale and AI...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency)

![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse")

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225 

#### Useful information

- [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/)
- [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions)
- [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)